CHAPTER 8: RABIES VACCINE MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Prophylaxis Type
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Product Type
8.2.6.1.2. Market size and forecast, by Prophylaxis Type
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Product Type
8.2.6.2.2. Market size and forecast, by Prophylaxis Type
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Product Type
8.2.6.3.2. Market size and forecast, by Prophylaxis Type
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Prophylaxis Type
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Product Type
8.3.6.1.2. Market size and forecast, by Prophylaxis Type
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Product Type
8.3.6.2.2. Market size and forecast, by Prophylaxis Type
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Product Type
8.3.6.3.2. Market size and forecast, by Prophylaxis Type
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Product Type
8.3.6.4.2. Market size and forecast, by Prophylaxis Type
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Product Type
8.3.6.5.2. Market size and forecast, by Prophylaxis Type
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Product Type
8.3.6.6.2. Market size and forecast, by Prophylaxis Type
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Prophylaxis Type
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Product Type
8.4.6.1.2. Market size and forecast, by Prophylaxis Type
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Product Type
8.4.6.2.2. Market size and forecast, by Prophylaxis Type
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Product Type
8.4.6.3.2. Market size and forecast, by Prophylaxis Type
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Product Type
8.4.6.4.2. Market size and forecast, by Prophylaxis Type
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Product Type
8.4.6.5.2. Market size and forecast, by Prophylaxis Type
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Product Type
8.4.6.6.2. Market size and forecast, by Prophylaxis Type
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Prophylaxis Type
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Product Type
8.5.6.1.2. Market size and forecast, by Prophylaxis Type
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Product Type
8.5.6.2.2. Market size and forecast, by Prophylaxis Type
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Product Type
8.5.6.3.2. Market size and forecast, by Prophylaxis Type
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Product Type
8.5.6.4.2. Market size and forecast, by Prophylaxis Type
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by End User
List of Tables
Table 01. Global Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 02. Rabies Vaccine Market for Chick Embryo Cells Rabies Vaccine, by Region, 2022-2032 ($Million)
Table 03. Rabies Vaccine Market for Vero Cell Rabies Vaccine, by Region, 2022-2032 ($Million)
Table 04. Rabies Vaccine Market for Human Diploid Cell Vaccine, by Region, 2022-2032 ($Million)
Table 05. Rabies Vaccine Market for Others, by Region, 2022-2032 ($Million)
Table 06. Global Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 07. Rabies Vaccine Market for Pre-Exposure Prophylaxis, by Region, 2022-2032 ($Million)
Table 08. Rabies Vaccine Market for Post-Exposure Prophylaxis, by Region, 2022-2032 ($Million)
Table 09. Global Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 10. Rabies Vaccine Market for Human, by Region, 2022-2032 ($Million)
Table 11. Rabies Vaccine Market for Animal, by Region, 2022-2032 ($Million)
Table 12. Global Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 13. Rabies Vaccine Market for Hospitals, by Region, 2022-2032 ($Million)
Table 14. Rabies Vaccine Market for Veterinary Clinics, by Region, 2022-2032 ($Million)
Table 15. Rabies Vaccine Market for Others, by Region, 2022-2032 ($Million)
Table 16. Rabies Vaccine Market, by Region, 2022-2032 ($Million)
Table 17. North America Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 18. North America Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 19. North America Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 20. North America Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 21. North America Rabies Vaccine Market, by Country, 2022-2032 ($Million)
Table 22. U.S. Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 23. U.S. Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 24. U.S. Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 25. U.S. Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 26. Canada Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 27. Canada Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 28. Canada Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 29. Canada Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 30. Mexico Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 31. Mexico Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 32. Mexico Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 33. Mexico Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 34. Europe Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 35. Europe Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 36. Europe Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 37. Europe Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 38. Europe Rabies Vaccine Market, by Country, 2022-2032 ($Million)
Table 39. Germany Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 40. Germany Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 41. Germany Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 42. Germany Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 43. France Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 44. France Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 45. France Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 46. France Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 47. UK Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 48. UK Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 49. UK Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 50. UK Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 51. Italy Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 52. Italy Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 53. Italy Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 54. Italy Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 55. Spain Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 56. Spain Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 57. Spain Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 58. Spain Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 59. Rest of Europe Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 60. Rest of Europe Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 61. Rest of Europe Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 62. Rest of Europe Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 63. Asia-Pacific Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 64. Asia-Pacific Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 65. Asia-Pacific Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 66. Asia-Pacific Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 67. Asia-Pacific Rabies Vaccine Market, by Country, 2022-2032 ($Million)
Table 68. Japan Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 69. Japan Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 70. Japan Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 71. Japan Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 72. China Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 73. China Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 74. China Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 75. China Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 76. India Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 77. India Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 78. India Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 79. India Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 80. Australia Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 81. Australia Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 82. Australia Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 83. Australia Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 84. South Korea Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 85. South Korea Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 86. South Korea Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 87. South Korea Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 88. Rest of Asia-Pacific Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 89. Rest of Asia-Pacific Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 90. Rest of Asia-Pacific Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 91. Rest of Asia-Pacific Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 92. LAMEA Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 93. LAMEA Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 94. LAMEA Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 95. LAMEA Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 96. LAMEA Rabies Vaccine Market, by Country, 2022-2032 ($Million)
Table 97. Brazil Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 98. Brazil Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 99. Brazil Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 100. Brazil Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 101. Saudi Arabia Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 102. Saudi Arabia Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 103. Saudi Arabia Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 104. Saudi Arabia Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 105. South Africa Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 106. South Africa Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 107. South Africa Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 108. South Africa Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 109. Rest of LAMEA Rabies Vaccine Market, by Product Type, 2022-2032 ($Million)
Table 110. Rest of LAMEA Rabies Vaccine Market, by Prophylaxis Type, 2022-2032 ($Million)
Table 111. Rest of LAMEA Rabies Vaccine Market, by Application, 2022-2032 ($Million)
Table 112. Rest of LAMEA Rabies Vaccine Market, by End-user, 2022-2032 ($Million)
Table 113. Bharat Biotech International Limited: Key Executives
Table 114. Bharat Biotech International Limited: Company Snapshot
Table 115. Bharat Biotech International Limited: Product Segments
Table 116. Bharat Biotech International Limited: Product Portfolio
Table 117. Sanofi: Key Executives
Table 118. Sanofi: Company Snapshot
Table 119. Sanofi: Product Segments
Table 120. Sanofi: Product Portfolio
Table 121. Boehringer Ingelheim International GmbH: Key Executives
Table 122. Boehringer Ingelheim International GmbH: Company Snapshot
Table 123. Boehringer Ingelheim International GmbH: Product Segments
Table 124. Boehringer Ingelheim International GmbH: Product Portfolio
Table 125. Boehringer Ingelheim International GmbH: Key Strategies
Table 126. Novartis AG: Key Executives
Table 127. Novartis AG: Company Snapshot
Table 128. Novartis AG: Product Segments
Table 129. Novartis AG: Product Portfolio
Table 130. Cadila Pharmaceuticals Ltd.: Key Executives
Table 131. Cadila Pharmaceuticals Ltd.: Company Snapshot
Table 132. Cadila Pharmaceuticals Ltd.: Product Segments
Table 133. Cadila Pharmaceuticals Ltd.: Product Portfolio
Table 134. Cadila Pharmaceuticals Ltd.: Key Strategies
Table 135. Merck & Co. Inc.: Key Executives
Table 136. Merck & Co. Inc.: Company Snapshot
Table 137. Merck & Co. Inc.: Product Segments
Table 138. Merck & Co. Inc.: Product Portfolio
Table 139. Serum Institute of India Pvt. Ltd.: Key Executives
Table 140. Serum Institute of India Pvt. Ltd.: Company Snapshot
Table 141. Serum Institute of India Pvt. Ltd.: Product Segments
Table 142. Serum Institute of India Pvt. Ltd.: Product Portfolio
Table 143. Zoetis Inc.: Key Executives
Table 144. Zoetis Inc.: Company Snapshot
Table 145. Zoetis Inc.: Product Segments
Table 146. Zoetis Inc.: Product Portfolio
Table 147. Elanco Animal Health Incorporated.: Key Executives
Table 148. Elanco Animal Health Incorporated.: Company Snapshot
Table 149. Elanco Animal Health Incorporated.: Product Segments
Table 150. Elanco Animal Health Incorporated.: Service Segments
Table 151. Elanco Animal Health Incorporated.: Product Portfolio
Table 152. Virbac SA: Key Executives
Table 153. Virbac SA: Company Snapshot
Table 154. Virbac SA: Product Segments
Table 155. Virbac SA: Product Portfolio
List of Figures
Figure 01. Rabies Vaccine Market, 2022-2032
Figure 02. Segmentation of Rabies Vaccine Market,2022-2032
Figure 03. Top Impacting Factors in Rabies Vaccine Market (2022 to 2032)
Figure 04. Top Investment Pockets in Rabies Vaccine Market (2023-2032)
Figure 05. Low Bargaining Power of Suppliers
Figure 06. Low Threat of New Entrants
Figure 07. Low Threat of Substitutes
Figure 08. Low Intensity of Rivalry
Figure 09. Low Bargaining Power of Buyers
Figure 10. Global Rabies Vaccine Market:Drivers, Restraints and Opportunities
Figure 11. Rabies Vaccine Market, by Product Type, 2022 and 2032(%)
Figure 12. Comparative Share Analysis of Rabies Vaccine Market for Chick Embryo Cells Rabies Vaccine, by Country 2022 and 2032(%)
Figure 13. Comparative Share Analysis of Rabies Vaccine Market for Vero Cell Rabies Vaccine, by Country 2022 and 2032(%)
Figure 14. Comparative Share Analysis of Rabies Vaccine Market for Human Diploid Cell Vaccine, by Country 2022 and 2032(%)
Figure 15. Comparative Share Analysis of Rabies Vaccine Market for Others, by Country 2022 and 2032(%)
Figure 16. Rabies Vaccine Market, by Prophylaxis Type, 2022 and 2032(%)
Figure 17. Comparative Share Analysis of Rabies Vaccine Market for Pre-Exposure Prophylaxis, by Country 2022 and 2032(%)
Figure 18. Comparative Share Analysis of Rabies Vaccine Market for Post-Exposure Prophylaxis, by Country 2022 and 2032(%)
Figure 19. Rabies Vaccine Market, by Application, 2022 and 2032(%)
Figure 20. Comparative Share Analysis of Rabies Vaccine Market for Human, by Country 2022 and 2032(%)
Figure 21. Comparative Share Analysis of Rabies Vaccine Market for Animal, by Country 2022 and 2032(%)
Figure 22. Rabies Vaccine Market, by End-user, 2022 and 2032(%)
Figure 23. Comparative Share Analysis of Rabies Vaccine Market for Hospitals, by Country 2022 and 2032(%)
Figure 24. Comparative Share Analysis of Rabies Vaccine Market for Veterinary Clinics, by Country 2022 and 2032(%)
Figure 25. Comparative Share Analysis of Rabies Vaccine Market for Others, by Country 2022 and 2032(%)
Figure 26. Rabies Vaccine Market by Region, 2022 and 2032(%)
Figure 27. U.S. Rabies Vaccine Market, 2022-2032 ($Million)
Figure 28. Canada Rabies Vaccine Market, 2022-2032 ($Million)
Figure 29. Mexico Rabies Vaccine Market, 2022-2032 ($Million)
Figure 30. Germany Rabies Vaccine Market, 2022-2032 ($Million)
Figure 31. France Rabies Vaccine Market, 2022-2032 ($Million)
Figure 32. UK Rabies Vaccine Market, 2022-2032 ($Million)
Figure 33. Italy Rabies Vaccine Market, 2022-2032 ($Million)
Figure 34. Spain Rabies Vaccine Market, 2022-2032 ($Million)
Figure 35. Rest of Europe Rabies Vaccine Market, 2022-2032 ($Million)
Figure 36. Japan Rabies Vaccine Market, 2022-2032 ($Million)
Figure 37. China Rabies Vaccine Market, 2022-2032 ($Million)
Figure 38. India Rabies Vaccine Market, 2022-2032 ($Million)
Figure 39. Australia Rabies Vaccine Market, 2022-2032 ($Million)
Figure 40. South Korea Rabies Vaccine Market, 2022-2032 ($Million)
Figure 41. Rest of Asia-Pacific Rabies Vaccine Market, 2022-2032 ($Million)
Figure 42. Brazil Rabies Vaccine Market, 2022-2032 ($Million)
Figure 43. Saudi Arabia Rabies Vaccine Market, 2022-2032 ($Million)
Figure 44. South Africa Rabies Vaccine Market, 2022-2032 ($Million)
Figure 45. Rest of LAMEA Rabies Vaccine Market, 2022-2032 ($Million)
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Rabies Vaccine Market
Figure 49. Top Player Positioning, 2022
Figure 50. Sanofi: Net Revenue, 2020-2022 ($Million)
Figure 51. Sanofi: Revenue Share by Segment, 2022 (%)
Figure 52. Sanofi: Revenue Share by Region, 2022 (%)
Figure 53. Boehringer Ingelheim International GmbH: Net Sales, 2020-2022 ($Million)
Figure 54. Boehringer Ingelheim International GmbH: Revenue Share by Segment, 2022 (%)
Figure 55. Boehringer Ingelheim International GmbH: Revenue Share by Region, 2022 (%)
Figure 56. Novartis AG: Net Sales, 2020-2022 ($Million)
Figure 57. Novartis AG: Revenue Share by Segment, 2022 (%)
Figure 58. Novartis AG: Revenue Share by Region, 2022 (%)
Figure 59. Merck & Co. Inc.: Net Revenue, 2020-2022 ($Million)
Figure 60. Merck & Co. Inc.: Revenue Share by Segment, 2022 (%)
Figure 61. Merck & Co. Inc.: Revenue Share by Region, 2022 (%)
Figure 62. Zoetis Inc.: Net Revenue, 2020-2022 ($Million)
Figure 63. Elanco Animal Health Incorporated.: Net Revenue, 2020-2022 ($Million)
Figure 64. Elanco Animal Health Incorporated.: Revenue Share by Segment, 2022 (%)
Figure 65. Elanco Animal Health Incorporated.: Revenue Share by Region, 2022 (%)
Figure 66. Virbac SA: Net Revenue, 2020-2022 ($Million)
Figure 67. Virbac SA: Revenue Share by Segment, 2022 (%)
Figure 68. Virbac SA: Revenue Share by Region, 2022 (%)